secwatch.observer — SEC 8-K summary
======================================

Issuer:     HCA Healthcare, Inc. (HCA)
CIK:        0000860730
Form:       8-K
Filed at:   2025-02-24T23:59:59+00:00
Accession:  0001193125-25-033430
Event type: leadership
Sentiment:  neutral
Materiality: 0.35
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

HCA director Crofton to retire at April 2025 annual meeting; exec incentive program adopted
--------------------------------------------------------------------------------

- Meg G. Crofton to retire from HCA board effective April 24, 2025 annual meeting.
- Compensation Committee adopted 2025 Executive Officer Performance Excellence Program for named execs.
- CEO Hazen target award 175% of base salary; CFO Marks and COO Foster 125%.
- Awards weighted 80% EBITDA and 20% quality metrics (HAI, sepsis, mortality, care experience).
- EBITDA portion: threshold 25%, target 100%, max 200% of target; quality metrics similar but no payout if EBITDA <90% of target.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/860730/000119312525033430/0001193125-25-033430-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/860730/000119312525033430/d927974d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-25-033430

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer